Placebo response to sham electroacupuncture in patients with chronic functional constipation: A secondary analysis
Neurogastroenterology & Motility · 2024
DOI: 10.1111/nmo.14770 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, 2024. Verfasst von Zhiyi Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, …. Hauptthemen laut MEDLINE: Constipation, Electroacupuncture, Placebo Effect. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Background
Chronic severe functional constipation is a common disease that requires novel and effective treatment strategies. Acupuncture might constitute a promising therapeutic approach for chronic constipation, but it reportedly engenders an enhanced placebo response. Herein, we aimed to determine the magnitude of the placebo responses to electroacupuncture for constipation and identify its influencing factors.
Methods
In this secondary analysis of a multicenter randomized trial, patients were randomized to a sham electroacupuncture group, which was administered for 8 weeks in 24 sessions of superficial needling at nonacupoints. The placebo response rates were assessed using three responder criteria: ≥3 complete spontaneous bowel movements per week (CSBMs/week), overall CSBM, and sustained CSBM. Logistic regression with backward selection method was employed to identify the potential factors that affected the placebo response. Key Results Overall, 539 patients were included in the study. The placebo response rate was 10.58%, 9.46%, and 9.09% according to the three aforementioned criteria, respectively. Those who exhibited more CSBMs/week at baseline were more likely to respond to sham electroacupuncture. Among patients with more than one CSBM per week at baseline, the response rates for achieving the criteria of ≥3 CSBMs per week, overall CSBM, and sustained CSBM were 25.40%, 30.16%, and 22.22%. Conclusions and Inference Electroacupuncture did not demonstrate a large placebo response in functional constipation treatment. The number of CSBMs at baseline may be a moderator of the placebo response to sham electroacupuncture. Thus, superficial needling sham acupuncture may be considered an ideal sham control for clinical trials of chronic constipation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
- College of Preschool Education, Beijing Youth Politics College, Beijing, China.
- China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Shiyan Yan
Förderung
- National Natural Science Foundation of China
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Xiong, Z., Ma, P., Zhang, H., Liu, C., Liu, B., Liu, Z., & Yan, S. (2024). Placebo response to sham electroacupuncture in patients with chronic functional constipation: A secondary analysis. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14770
Vancouver
Xiong Z, Ma P, Zhang H, Liu C, Liu B, Liu Z, et al. Placebo response to sham electroacupuncture in patients with chronic functional constipation: A secondary analysis. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14770
BibTeX
@article{Xiong2024,
author = {Xiong, Zhiyi and Ma, Peihong and Zhang, Haoran and Liu, Cunzhi and Liu, Baoyan and Liu, Zhishun and Yan, Shiyan},
title = {Placebo response to sham electroacupuncture in patients with chronic functional constipation: A secondary analysis},
journal = {Neurogastroenterology & Motility},
year = {2024},
doi = {10.1111/nmo.14770}
}
EUVIMED